Fior Markets launched a study titled “Histopathology Testing Equipment Market by Product Type (Instruments, Consumables), Application, End User, Regions”,and Global Forecast 2018-2025.

The global histopathology testing equipment market is expected to grow from USD 5.63 Billion in 2017 to USD 7.93 Billion by 2025, at a CAGR of 4.37% during the forecast period from 2018-2025. Growing awareness regarding cancer screening tests along with increasing demand for the advanced histopathology testing equipment’s from the diagnostic centers are anticipated to boost the global histopathology testing equipment market.


Consumables segment had a market value of USD 4.08 billion in 2017

Product type segment is divided into instruments and consumables. Product type is further segmented into tissue processor equipment, tissue embedding equipment, slide strainers systems, cover slipper systems, microtome & cryostat, microscopes, others. Consumables segment is fragmented into reagents & antibodies, probes, kits, others. Factors such as rising demand for reagents and antibodies as well as increasing use of reagents and kits in genomics, sequencing and diagnosis of chronic diseases, led consumables segment to emerge as the dominant segment with USD 4.08 billion revenue in 2017.

Drug discovery segment is anticipated to grow at a CAGR of 6.72% in 2018-2025

Application is segmented into drug discovery, disease diagnostics and research application. Disease diagnostics segment emerged as the leader in the global histopathology testing equipmentmarket with USD 2.43 billion revenue in 2017. However drug discovery segment is projected to progress at an accelerated CAGR of 6.72% over the forecast period.

Diagnostic centers segment had a market value of USD 3.21 billion in 2017

End user segment is categorized into hospital based laboratories, diagnostic centers and research organizations.Owing to factors such as rising number of referrals to the diagnostics centers as well as growing private investment in the diagnostics sector, the diagnostic centers emerged as the leading end user segment with USD 3.21 billion in 2017.


Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. North America emerged as the leading region in the global histopathology testing equipment market with USD 2.34 billion revenue in 2017. Factors such as rapidly developing healthcare and medical sector as well as growing investment on the improving the standards of the healthcare facilities in the region, are anticipated to propel this increased growth.

Competitive Analysis:

Major players in the global histopathology testing equipment market are Thermo Fisher Scientific, Hoffman-la-Roche Ltd., Leica Biosystems, Agilent Technologies Inc., Merck KGaA, Cardinal Health Inc, Advanced Cell Diagnostics Inc, Abbott Laboratories, Abcam, Sakura Fintek, Oxford Cancer Biomarkers, Nucleix, Monogram Biosciences, Omnyx, and among others.

Customization of the Report:This report can be customized to meet the client’s requirements. Please connect with our sales team (, who will ensure that you get a report that suits your needs.